Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119188722 | 11918872 | 2 | F | 200311 | 20160720 | 20160115 | 20160907 | PER | US-JNJFOC-20151205170 | JANSSEN | 48.31 | YR | A | F | Y | 90.72000 | KG | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119188722 | 11918872 | 1 | PS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 20634 | 500 | MG | TABLETS | ||||||
| 119188722 | 11918872 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | U | 0 | 500 | MG | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119188722 | 11918872 | 1 | Product used for unknown indication |
| 119188722 | 11918872 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119188722 | 11918872 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119188722 | 11918872 | Musculoskeletal pain | |
| 119188722 | 11918872 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119188722 | 11918872 | 1 | 20031031 | 20140331 | 0 | |
| 119188722 | 11918872 | 2 | 20040820 | 20120531 | 0 |